Nanomedicine Therapies Current Events | Nanomedicine Therapies News | 5
|
| Page
5 of
10 |
195 Results |
|
|
|
Sort By:
Page Views | Date |
Severe Pain Relief may be Possible with a Common Anesthetic Drug
A novel treatment using a common anesthetic drug has shown success in reducing the severe pain caused by Complex Regional Pain Syndrome (CRPS), according to a study published in the September 2004 issue of Pain Medicine. CRPS, a disorder that can be associated with chronic pain resistant to conventional therapies, affects between 1.5 and 7 million... view more... (2004-10-12)
Implant bacteria, beware: Researchers create nano-sized assassins
Staphylococcus epidermidis is quite an opportunist. Commonly found on human skin, the bacteria pose little danger. But S. epidermidis is a leading cause of infections in hospitals. view more (2009-06-26)
Severe psoriasis associated with increased risk of death
Patients with severe psoriasis appear to have an increased risk of death compared with patients without the skin condition, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. view more (2007-12-18)
Menopausal women don't get enough guidance on treatment options
Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms. view more (2006-06-19)
Breast cancer awareness calls for cardiovascular awareness
Women who overcome breast cancer have every reason to celebrate. But a heart filled with joy may also be a heart damaged by life-saving cancer therapies, a growing body of research shows. view more (2007-10-12)
First compound that specifically kills cancer stem cells found
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. view more (2009-08-14)
Exploiting Nature's Weapons in the Fight Against Diabetes
Scientists at the University of Ulster are harnessing molecules produced naturally in the body to tackle one of the world's major health problems - diabetes. Their novel approach involves bioengineering gut peptides - molecules produced in the human intestine and released in response to feeding - to prolong their duration of action and,... view more... (2004-03-23)
Information about the use and accuracy of breast cancer tests is lacking, study finds
A new study finds that there is little information available about the use of new testing technologies and targeted therapies in breast cancer, specifically the anti-cancer drug trastuzumab (Herceptin). view more (2009-09-14)
Treatment-induced growth factor causes cancer progression
In advanced cancer, anti-tumor therapies often work only partially or not at all, and tumors progress following treatment. view more (2007-04-06)
Class of medications may offer alternative option for treating type 2 diabetes
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic... view more... (2007-07-11)
Novel vaccine shows promise against early-stage breast cancer
A diagnosis of breast cancer has taken on a new meaning in the past 10 years, as research has produced a host of new therapies and detection techniques, significantly improving long-term survival for women who have been fighting the disease. view more (2006-11-13)
Organon, University of Twente and Delft University of Technology are jointly searching for innovative therapies to promote bone regeneration
The Dutch pharmaceutical company Organon, the University of Twente (UT) and the Delft University of Technology have jointly started a project with the goal of finding breakthroughs in our understanding of the mechanisms of bone formation. This should lead to the development of new drugs and protocols for tissue engineering. This will strengthen... view more... (2004-03-22)
UCLA researchers identify leukemia stem cells
Stem cell researchers at UCLA have identified a type of leukemia stem cell and uncovered the molecular and genetic mechanisms that cause a normal blood stem cells to become cancerous. view more (2008-05-27)
Combination anti-retroviral therapies associated with reduced infections in HIV-infected children
Since the introduction of highly active antiretroviral therapies, there has been a substantial reduction of opportunistic infections and other infections in HIV-infected children, such as pneumonia and tuberculosis. view more (2006-07-19)
Ipsat Therapies Announces Positive Clinical Trial Results for the Prevention of Serious Infections Associated with Antibiotic Resistance
Helsinki, October 13th 2003 - Ipsat Therapies, focused on developing products to prevent the spread of serious infections associated with antibiotic therapy and resistance, today presented positive Phase I clinical trial data for its lead product, P1A, at the BioPartnering Europe Conference in London. This product fulfils many of the criteria for... view more... (2003-10-13)
Withdrawal of life support often an imperfect compromise
Intensive Care Unit (ICU) doctors seeking to balance the complex needs of their patients and the patients' families may make an imperfect compromise, withdrawing life support systems over a prolonged period of time. view more (2008-10-07)
The vasculature emerges as a potential therapeutic target in treating ADPKD liver cysts
As part of an effort to develop effective medical therapies that block the progression of liver cyst growth in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), researchers at the University of Colorado Anschutz Medical Center have found that the liver cyst walls develop and maintain a vasculature as they grow out from the body... view more... (2009-09-24)
NYU researchers developing molecular delivery vehicles for genetic therapies
Researchers at New York University are working to develop molecular delivery vehicles that can be used to transport nucleic acids into diverse cell types, which may lead to eventual applications in genetic therapies. view more (2006-11-14)
Study shows microRNA-based diagnostic identifies squamous lung cancer with 96 percent sensitivity
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity, according to Harvey Pass, M.D. of the NYU Cancer Institute at NYU Langone Medical Center, one of the authors of the study published on-line ahead of print in the Journal of Clinical Oncology. view more (2009-03-10)
FOSRENOL significantly reduces tablet burden for end-stage renal patients with hyperphosphatemia
According to data presented today at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia,... view more... (2006-04-21)
|
|
| Page
5 of
10 |
195 Results |
|
|
|
Sort By:
Page Views | Date |
|
